A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental study, pharmacological inhibition of an enzyme that plays a central role in ...

The Barbara Ann Karmanos Cancer Institute, the largest provider of cancer care and research in Michigan and part of McLaren ...

It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

4 The liver cancer treatment pattern has changed in recent years with the emergence of immunotherapy combinations and will continue to evolve as more treatment options become available for these ...

Liver elastography confirms liver fibrosis (stiffness) and helps providers reach a diagnosis to suggest treatment. Learn ...

Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at ...

Liver cancer is a disease with a poor prognosis. Despite multiple therapeutic options, including the recent emergence of immunotherapy as a first-line systemic treatment, the outcomes remain poor.

Chris Donaldson was told he had just a few years to live after cancer in his eyes spread to his liver. But he received a new ...

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either ...

Dan G. Duda, DMD, PhD, of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published in ...